Feature Channels: Pharmaceuticals

Filters close
Released: 14-Feb-2024 4:05 AM EST
Can Olive Oil Reverse Genetic Predisposition for Alzheimer’s?
Alzheimer's Center at Temple University Lewis Katz School of Medicine

Clinical studies suggest the Mediterranean diet, and one of its main components, extra virgin olive oil (EVOO), improves cognitive function and slows Alzheimer's disease (AD) progression. Researchers will now investigate whether this is true even for people with a family history of AD and signs of genetic predisposition caused by dysfunction in the APOE gene.

Released: 13-Feb-2024 10:30 AM EST
SLU Professor Shows Ethical Duality of Using Prescription Drug Monitoring Programs in Fight Against Opioids
Saint Louis University Medical Center

Saint Louis University’s Liz Chiarello, Ph.D., associate professor of sociology recently published an article in the American Sociological Review, the flagship journal of the American Sociological Association. The article explores pharmacists’ use of prescription drug monitoring programs (PDMPs) and the ethical and practical application of PDMPs in healthcare.

Newswise: Sandalwood Oil By-product Prevents Prostate Cancer Development in Mice
Released: 13-Feb-2024 8:30 AM EST
Sandalwood Oil By-product Prevents Prostate Cancer Development in Mice
Florida Atlantic University

Sandalwood oil has been used worldwide for centuries. Now, a study is the first to demonstrate in vivo the chemo-preventive properties of a by-product of the oil in a mouse model. Results show administering alpha-santalol reduced visible prostate tumors, protected the normal tissue, and delayed progression from a precancerous condition to a high-grade form of cancer. These findings are significant because mortality in prostate cancer patients is mainly attributable to advanced stages of the disease.

Released: 12-Feb-2024 11:05 AM EST
Antibody drug conjugates make strides in ovarian cancer with recent FDA approval
University of California, Los Angeles (UCLA), Health Sciences

The UCLA team played a pivotal role in a clinical trial that led to the FDA granting accelerated approval of the first antibody drug conjugate (ADC), mirvetuximab soravtansine, for the treatment of platinum-resistant ovarian cancer.

Released: 7-Feb-2024 5:00 PM EST
MD Anderson and C-Biomex sign collaborative research agreement to co-develop CBT-001 radioligand therapy
University of Texas MD Anderson Cancer Center

MD Anderso and C-Biomex today announced a strategic collaboration to co-develop CBT-001, a radioligand targeting the CA9 cancer biomarker.

Newswise: Covid vaccine for pregnant women safe for newborn infants
Released: 7-Feb-2024 1:05 AM EST
Covid vaccine for pregnant women safe for newborn infants
Karolinska Institute

No increased risks for babies, and for some serious neonatal complications lower risks.

Released: 5-Feb-2024 2:05 PM EST
Methadone Use in Early Pregnancy May Lead to More Birth Defects Than Buprenorphine
Rutgers University-New Brunswick

Analysis from Rutgers Health and Harvard links first-trimester methadone use with a greater risk of various birth defects than buprenorphine use.

Released: 1-Feb-2024 10:05 PM EST
Gut bacteria can process dietary fiber into an anti-allergy weapon, finds new study
Tokyo University of Science

The intricate relationship that exists between humans and the gut microbiome has become a hot research topic, and scientists are constantly uncovering new reasons why a healthy diet can lead to a healthier life.

Newswise:Video Embedded live-event-nurses-the-most-trusted-profession-in-an-age-of-mistrust
VIDEO
Released: 1-Feb-2024 5:00 PM EST
VIDEO AND TRANSCRIPT: Nurses -- The Most Trusted Profession in an Age of Mistrust
Newswise

For 21 years, nurses have consistently been the most trusted profession, according to the yearly Gallup poll. (The new poll will be issued by the end of January). Dr Rushton, who specializes in burnout, will speak on trust, moral injury, and how nurses cope in this day and age.

Released: 1-Feb-2024 12:05 PM EST
American Society of Anesthesiologists welcomes improvements to No Surprises Act IDR process
American Society of Anesthesiologists (ASA)

The American Society of Anesthesiologists (ASA) commends the Centers for Medicare & Medicaid Services (CMS) for taking positive steps towards returning balance to the independent dispute resolution (IDR) process of the No Surprises Act (NSA) through a recently proposed rule.

Released: 31-Jan-2024 5:05 PM EST
Molecule can quickly, and briefly, boost white blood cell counts
Yale University

Treatment with a molecule known as A485 can quickly and temporarily increase levels of white blood cells, a critical part of the body’s immune system, an effect that is difficult to deliver with currently available pharmaceuticals, a new Yale study finds.

Newswise: Engineering viruses to kill deadly pathogens
Released: 31-Jan-2024 12:05 PM EST
Engineering viruses to kill deadly pathogens
Northwestern University

Northwestern University researchers have successfully coaxed a deadly pathogen to destroy itself from the inside out.

Released: 30-Jan-2024 1:05 PM EST
DNA particles that mimic viruses hold promise as vaccines
Massachusetts Institute of Technology (MIT)

Using a virus-like delivery particle made from DNA, researchers from MIT and the Ragon Institute of MGH, MIT, and Harvard have created a vaccine that can induce a strong antibody response against SARS-CoV-2.

Newswise: MD Anderson designated IAEA Collaborating Centre to focus on improving radiation, radiology and nuclear medicine worldwide
Released: 30-Jan-2024 10:05 AM EST
MD Anderson designated IAEA Collaborating Centre to focus on improving radiation, radiology and nuclear medicine worldwide
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center today announced the signing of an agreement with the International Atomic Energy Agency (IAEA) to become an IAEA Collaborating Centre.

Released: 24-Jan-2024 1:05 PM EST
UC Irvine-led study links biomarkers and chemotherapy-related gastrointestinal symptoms
University of California, Irvine

A study led by University of California, Irvine researchers has revealed a connection between blood levels of omega-3 and the inflammatory biomarker interleukin-8 and greater chemotherapy-related gastrointestinal symptoms in breast cancer patients.

Newswise: Quickly and easily predict emerging contaminant concentrations in wastewater with artificial intelligence
Released: 23-Jan-2024 12:00 AM EST
Quickly and easily predict emerging contaminant concentrations in wastewater with artificial intelligence
National Research Council of Science and Technology

The Korea Institute of Science and Technology (KIST) announced that a team led by Hong Seok-won, head of the Water Resources and Cycle Research Center, and Son Moon, a senior researcher, has developed a technology to classify emerging trace substances according to their physicochemical properties and predict their concentrations using clustering and prediction-based artificial intelligence technology.

Newswise: New biomarkers for active lupus nephritis discovered
Released: 22-Jan-2024 4:05 PM EST
New biomarkers for active lupus nephritis discovered
University of Houston

New biomarkers with improved diagnostic performance for early detection of lupus nephritis have been discovered in the University of Houston lab of Chandra Mohan, a pioneer in lupus research.

Released: 22-Jan-2024 4:05 PM EST
New candidate for universal memory is fast, low-power, stable and long-lasting
Stanford University

We are tasking our computers with processing ever-increasing amounts of data to speed up drug discovery, improve weather and climate predictions, train artificial intelligence, and much more.

Newswise: A new drug candidate can shrink kidney cysts
Released: 22-Jan-2024 4:05 PM EST
A new drug candidate can shrink kidney cysts
Massachusetts Institute of Technology (MIT)

Autosomal dominant polycystic kidney disease (ADPKD), the most common form of polycystic kidney disease, can lead to kidney enlargement and eventual loss of function.

Released: 22-Jan-2024 1:05 PM EST
New Reagent Improves the Process of Making Sulfur-Containing Compounds that May Be Used in Medicines
Moffitt Cancer Center

In a new article published in Nature Chemistry, Moffitt Cancer Center researchers describe their development of a new reagent that allows a more efficient approach to make sulfoximines, sulfonimidoyl fluorides and sulfonimidamides that may be used in medicines.

Released: 22-Jan-2024 1:05 PM EST
Protein discovery could help solve prostate cancer drug resistance
Washington State University

Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells’ resistance to docetaxel, a commonly used chemotherapy drug to treat advanced cancer that has spread beyond the prostate.

Newswise: Wake Forest Institute for Regenerative Medicine (WFIRM) to lead $40 Million initiative for AFIRM Consortium
Released: 22-Jan-2024 12:00 PM EST
Wake Forest Institute for Regenerative Medicine (WFIRM) to lead $40 Million initiative for AFIRM Consortium
Wake Forest Institute for Regenerative Medicine

The Wake Forest Institute for Regenerative Medicine, part of Wake Forest University School of Medicine, has been selected to lead the Armed Forces Institute of Regenerative Medicine (AFIRM) Consortium.

   
Released: 22-Jan-2024 11:05 AM EST
American Society of Anesthesiologists (ASA) Welcomes Vince Loffredo, Ed.D., as Chief Learning Officer
American Society of Anesthesiologists (ASA)

In a strategic move, ASA has hired Vince Loffredo, Ed.D., as its new Chief Learning Officer, where he will oversee the Education, Meetings, and Publications departments, as well as serve as a vital member of ASA’s CEO team.

Newswise: Cedars-Sinai Develops New Tools to Improve Pancreatic Cancer Patient Care
Released: 22-Jan-2024 11:05 AM EST
Cedars-Sinai Develops New Tools to Improve Pancreatic Cancer Patient Care
Cedars-Sinai

Cedars-Sinai Cancer investigators have used a unique precision medicine and artificial intelligence (AI) tool called the Molecular Twin Precision Oncology Platform to identify biomarkers that outperform the standard test for predicting pancreatic cancer survival.

Released: 22-Jan-2024 10:05 AM EST
Strategy to Boost Prostate Cancer Treatment Efficacy Devised at Rutgers Health
Rutgers University-New Brunswick

Research shows why prostate cancer cells grow and spread in only some patients.

Newswise: Scientists increase the solubility of an effective antidepressant by 1600 times
Released: 22-Jan-2024 4:05 AM EST
Scientists increase the solubility of an effective antidepressant by 1600 times
Scientific Project Lomonosov

GML-3, synthesized at V.V. Zakusov Research Institute of Pharmacology, with a complex effect against depression, is practically free of side effects.

   
Released: 19-Jan-2024 1:05 PM EST
Bacterial meningitis damages one in three children for life
Karolinska Institute

One in three children who suffer from bacterial meningitis live with permanent neurological disabilities due to the infection.

Released: 19-Jan-2024 1:05 PM EST
Stuck in traffic: Researchers identify cellular traffic jams in a rare disease
McGill University

Researchers from McGill University, led by Professor Alanna Watt of the Department of Biology, have identified previously unknown changes in brain cells affected by a neurological disease.

Released: 19-Jan-2024 1:05 PM EST
Don't wait for an emergency to get the latest emergency medicine news
Newswise

Find the latest research and features on emergency medicine in the Emergency Medicine channel on Newswise.

       
Newswise: Study Examines Substance Use in First Responders During  COVID-19 Pandemic
Released: 18-Jan-2024 8:30 AM EST
Study Examines Substance Use in First Responders During COVID-19 Pandemic
Florida Atlantic University

Little is known about the factors associated with first responder drug and alcohol use during the pandemic. A new study shows that nearly 40 percent of law enforcement personnel, firefighters and emergency medical service providers reported using substances to relieve emotional discomfort during COVID-19.

   
17-Jan-2024 5:00 AM EST
CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies
University of Texas MD Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center reported promising results in a Phase I/II trial of 37 patients with relapsed or refractory B-cell malignancies who were treated with cord blood-derived chimeric antigen receptor (CAR) natural killer (NK) cell therapy targeting CD19.

Newswise: Bioengineered approach shows promise in ulcerative colitis
Released: 16-Jan-2024 10:05 AM EST
Bioengineered approach shows promise in ulcerative colitis
UT Southwestern Medical Center

By taking advantage of mechanisms that allow cancer cells to evade immune attack, UT Southwestern Medical Center researchers have developed a new strategy in animal models that has potential for treating ulcerative colitis.

Not for public release

This news release is embargoed until 15-Jan-2024 5:00 PM EST Released to reporters: 9-Jan-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 15-Jan-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 15-Jan-2024 10:05 AM EST
Accelerating how new drugs are made with machine learning
University of Cambridge

Researchers have developed a platform that combines automated experiments with AI to predict how chemicals will react with one another, which could accelerate the design process for new drugs.

   
Released: 12-Jan-2024 10:15 AM EST
Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center’s ALS Center is the First in the Nation to Offer Patients a New Interventional Clinical Study
Hackensack Meridian Health

Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center’s ALS Center is the first ALS care provider in the United States to offer patients a new interventional clinical study.

Newswise: Scientists Reveal Role of Notorious Cell Subpopulation in Antibiotic Failure
Released: 11-Jan-2024 11:05 AM EST
Scientists Reveal Role of Notorious Cell Subpopulation in Antibiotic Failure
University of North Carolina Health Care System

Antibiotic overuse can lead to antibiotic resistance, a global health problem. But UNC School of Medicine scientists with Duke School of Medicine colleagues have documented another culprit in clinical antibiotic failure: bacterial persister cells.

   

Not for public release

This news release is embargoed until 10-Jan-2024 11:00 AM EST Released to reporters: 8-Jan-2024 4:05 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 10-Jan-2024 11:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Study suggests key to antipsychotic drug-induced obesity
Released: 8-Jan-2024 12:05 PM EST
Study suggests key to antipsychotic drug-induced obesity
UT Southwestern Medical Center

An increased concentration of the hormone leptin in fat cells is believed to be responsible for weight gain associated with antipsychotic drugs, according to research led by UT Southwestern Medical Center. The study, published in Science Translational Medicine, used a mouse model to uncover the underlying mechanisms of unwanted metabolic side effects and to test an antibody that might reduce them.

Released: 8-Jan-2024 12:05 PM EST
Could a drug prevent hearing loss from loud music and aging?
University of California, San Francisco (UCSF)

Researchers have found a gene that links deafness to cell death in the inner ear in humans – creating new opportunities for averting hearing loss.

Newswise: Protein Structures Signal Fresh Targets for Anticancer Drugs
Released: 5-Jan-2024 3:05 PM EST
Protein Structures Signal Fresh Targets for Anticancer Drugs
Department of Energy, Office of Science

Cell replication in our bodies is triggered by a cascade of molecular signals transmitted between proteins. Compounds that block these signals show potential as cancer drugs. Recently, scientists uncovered the molecular mechanisms that underlie a step in the signal-transmission pathway that requires three proteins to link up. This points the way to new targets for drugs that fight certain types of cancer.

Released: 4-Jan-2024 4:05 PM EST
Treating tuberculosis when antibiotics no longer work
University of Cologne

In cooperation with research partners in Germany and France, the infectious disease specialist Dr Jan Rybniker and his team at University Hospital Cologne and the University of Cologne’s Faculty of Medicine have identified new, antibiotic molecules that target Mycobacterium tuberculosis and make it less pathogenic for humans.

Released: 4-Jan-2024 2:00 PM EST
Starting a family with the help of science: The latest research in Fertility
Newswise

Find the latest research and features on fertility in the Fertility News Source on Newswise.

       
Newswise: Removing the Penicillin Allergic Label: Researchers Introduce PADME
Released: 4-Jan-2024 1:05 PM EST
Removing the Penicillin Allergic Label: Researchers Introduce PADME
University of North Carolina Health Care System

Doctors at the UNC School of Medicine and Cincinnati Children’s collaborate to develop an innovative, patient-initiated online platform designed to remove the penicillin allergy label from misdiagnosed pediatric patients.

Newswise: Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVID
4-Jan-2024 10:10 AM EST
Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVID
University of California, San Francisco (UCSF)

A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.

Newswise: Minimizing Immunotherapy’s Potentially Harmful Side Effects
2-Jan-2024 1:05 PM EST
Minimizing Immunotherapy’s Potentially Harmful Side Effects
Sylvester Comprehensive Cancer Center

New research from Sylvester Comprehensive Cancer Center indicates that providing prophylactic treatment before immunotherapy can significantly reduce the rate of cytokine release syndrome (CRS) in multiple myeloma patients. Study appears Jan. 4, 2024, in Blood Cancer Discovery.



close
2.32239